Conclusion
PAD
The HCST is a valid and reliable patient-reported objective assessment tool of SUI in surgical clinical trials with good specificity, sensitivity, and consistency that eliminates the need for hospital visits and assessor’s bias. HCST can replace the 24-h pad tests in future trials. Further research is required to see if it translates to better retention in clinical trials and before it can be used in standard clinical practice.
